You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsed, refractory hematologic malignancies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aggressive B-Cell Non-Hodgkin's Lymphoma, Aggressive B-Cell NHL, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial

Not yet recruiting
  • Aggressive B-Cell Non-Hodgkin's Lymphoma
  • +4 more
  • (no location specified)
Dec 16, 2022

Cognitive Aftereffects of Neurotoxicity in Children and Young

Not yet recruiting
  • Lymphoma
  • Leukemia
    • Los Angeles, California
    • +2 more
    Feb 2, 2023

    Multiple Myeloma, Acute Myeloid Leukemia, Non Hodgkin Lymphoma Trial in United States (PRT1419)

    Completed
    • Multiple Myeloma
    • +3 more
    • Denver, Colorado
    • +4 more
    Nov 14, 2022

    Multiple Myeloma (MM), DLBCL, Not Otherwise Specified, Double Hit Lymphoma Trial in Spain (IDP-121)

    Recruiting
    • Multiple Myeloma (MM)
    • +5 more
    • Santander, Cantabria, Spain
    • +4 more
    Jun 19, 2023

    Relapsed or Refractory Hematologic Malignancies Trial in Chicago (Omacetaxine, Venetoclax)

    Recruiting
    • Relapsed or Refractory Hematologic Malignancies
    • Chicago, Illinois
      University of Illinois Cancer Center
    Sep 27, 2022

    Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Trial in United States (PRT1419)

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Orange City, Florida
    • +7 more
    Oct 31, 2022

    Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma Trial (SYHX1903)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • (no location specified)
    Sep 14, 2021

    Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

    Recruiting
    • Non-hodgkin Lymphoma
    • +2 more
    • CC312
    • Tianjin, Tianjin, China
      InstituteHBDH
    Sep 12, 2023

    Adult Relapsed/Refractory B-cell Hematologic Malignancies Trial in Beijing (CD19-CAR-NK)

    Recruiting
    • Adult Relapsed/Refractory B-cell Hematologic Malignancies
    • CD19-CAR-NK
    • Beijing, Beijing, China
      The Fifth Medical Center of Chinese People's Liberation Army (PL
    Dec 1, 2022

    Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

    Not yet recruiting
    • Relapsed/Refractory Chronic Lymphocytic Leukemia
    • Tianjin, Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Jul 13, 2023

    Non-hodgkin's Lymphoma Trial in Beijing (GNC-035)

    Not yet recruiting
    • Non-hodgkin's Lymphoma
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Sep 27, 2023

    Lymphoma, Non-Hodgkin Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Vysis LSI MYC Break Apart Rearrangement

    Recruiting
    • Lymphoma
    • +4 more
    • Vysis LSI MYC Break Apart Rearrangement Probe Kit
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Tumors, Hematologic Tumors, Tumors by Site Trial in Wuhan (RD13-02 cell infusion)

    Recruiting
    • Neoplasms
    • +3 more
    • RD13-02 cell infusion
    • Wuhan, Hubei, China
      Union Hospital, Huazhong University of Science and Technology
    Jun 8, 2023

    Relapsed or Refractory B-cell Hematologic Malignancies Trial in Beijing, Nanjing (HEC89736)

    Active, not recruiting
    • Relapsed or Refractory B-cell Hematologic Malignancies
    • Beijing, Beijing, China
    • +1 more
    May 5, 2022

    Hematological Malignancies Trial in Guangzhou, Tianjin (Nemtabrutinib)

    Recruiting
    • Hematological Malignancies
    • Guangzhou, Guangdong, China
    • +2 more
    Aug 10, 2022

    Hematologic Malignancies Trial in Shanghai (GNC-035)

    Recruiting
    • Hematologic Malignancies
    • Guiyang, Guizhou, China
    • +3 more
    Jan 13, 2023

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical

    Recruiting
    • Acute Myeloid Leukemia
    • +10 more
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Mar 1, 2022

    Hematological Malignancies Trial (Anti-CD7 CAR-T)

    Not yet recruiting
    • Hematological Malignancies
    • Anti-CD7 CAR-T
    • (no location specified)
    Jul 8, 2022

    Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy Trial in United States (Emavusertib, ibrutinib)

    Recruiting
    • Relapsed Hematologic Malignancy
    • Refractory Hematologic Malignancy
    • Phoenix, Arizona
    • +10 more
    Feb 1, 2023

    Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Xuzhou (allogenic CD19-CAR-NK cells)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • allogenic CD19-CAR-NK cells
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Feb 11, 2023

    Hematological Malignancies, Multiple Myeloma, Hodgkin's Lymphoma Trial in Worldwide (Tinostamustine)

    Recruiting
    • Hematological Malignancies
    • +3 more
    • Phoenix, Arizona
    • +19 more
    Apr 12, 2022

    Relapsed and/or Refractory Acute Myeloid Leukemia, High Risk Hematologic Malignancies Trial in Langfang (anti-CD33 CAR T cells)

    Not yet recruiting
    • Relapsed and/or Refractory Acute Myeloid Leukemia
    • High Risk Hematologic Malignancies
    • anti-CD33 CAR T cells
    • Langfang, Hebei, China
      Hebei Yanda Lu Daopei Hospital
    Jun 30, 2022

    Relapsed/Refractory, High Risk Hematologic Malignancies, T-ALL/Lymphoma Trial in Langfang (CD7CAR T cells)

    Recruiting
    • Relapsed/Refractory, High Risk Hematologic Malignancies
    • T-ALL/Lymphoma
    • CD7CAR T cells
    • Langfang, Hebei, China
      Hebei Yanda Lu Daopei Hospital
    Jun 30, 2022

    Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +4 more
    • Utrecht, Netherlands
      Princess Máxima Center for Pediatric Oncology
    Feb 22, 2023

    Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +4 more
    • Utrecht, Netherlands
      Princess Máxima Center for Pediatric Oncology
    Feb 20, 2023